Macquarie Group’s American Oncology Network, Inc. Class A Common Stock AONC Stock Holding History
Bought
Maintained
Sold
Other funds holding AONC
CH
SCM
AIMCA
AA
UOC
GCL
FTCM
SCM
KIM
MSU
Macquarie Group's AONC Position: Q1 2023 in Review
Macquarie Group sold out of American Oncology Network, Inc. Class A Common Stock (AONC) in Q1 2023, closing a stake of 1,375,000 shares — an estimated $13.8M sold.
Macquarie Group first reported a position in AONC in Q3 2021 and held it in 6 quarters. The position peaked at $13.8M in Q4 2022. 13 funds tracked by Wall St. Rank hold AONC as of Q1 2023.
- Macquarie Group reported no remaining American Oncology Network, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Macquarie Group sold 1,375,000 American Oncology Network, Inc. Class A Common Stock shares in Q1 2023, an estimated $13.8M.
- Macquarie Group first reported a position in American Oncology Network, Inc. Class A Common Stock in Q3 2021 and held it in 6 quarters.
- Macquarie Group's American Oncology Network, Inc. Class A Common Stock position peaked at $13.8M in Q4 2022.
- 13 funds tracked by Wall St. Rank held American Oncology Network, Inc. Class A Common Stock as of Q1 2023.
Based on Macquarie Group's 13F filing for Q1 2023, filed 15 May 2023.